BioSpace News Archive

Following a change to U.S. corporate tax laws, Pfizer announced at the beginning of this year that it intends to invest $5 billion in U.S. manufacturing over the next five years. On Tuesday, Pfizer showed its commitment to that promise with a $465 million investment in a new Michigan manufacturing site that is expected to create more than 450 jobs.

Celgene announced data from its Phase III AUGMENT clinical trial that compared Revlimid (lenalidomide) and rituximab to placebo in relapsed/refractory follicular and marginal zone lymphoma.

Invitae Corporation announced that it will report its second quarter 2018 financial results on Tuesday, August 7, 2018 and will host a conference call and webinar that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent highlights.

Metagenics Inc. announced that it was awarded the USP Quality Systems GMP Audited Certificate by USP for its Gig Harbor, Washington, manufacturing facilities.

Sales of $8.4 billion, up 7.4 percent year-on-year

Dane joins executive team of Atlanta firm providing technology solution to opioid crisis; brings banking, medical device industry expertise to lead Intent’s finance operations

Bill Earley, the chief administrative officer and general counsel at West Health, has been appointed to the California Commission on Aging (CCoA) by the Senate Rules Committee, with President pro Tempore of the California State Senate Toni Atkins leading the appointment as chair of the committee.

Medi-Tate Ltd. announced the enrollment of the first fifty patients in its second multi-center European study on the iTind

Aldeyra Therapeutics, inc., today announced that the first patient has enrolled in a pivotal Phase 3 clinical trial of topical dermal reproxalap for the treatment of ichthyosis.

Sutro’s Cell-free Protein Synthesis Technology is Paired With Merck’s Immunology & Cancer Expertise